Terms: = Endocrine gland cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Treatment
183 results:
1. [Testicular involvement in pediatric lymphoid tumors: a review of the literature and a series of clinical observation].
Korneeva M S; Batmanova N A; Panferova T R; Valiev T T
Urologiia; 2024 Mar; (1):107-112. PubMed ID: 38650415
[TBL] [Abstract] [Full Text] [Related]
2. Artificial intelligence for assessment of vascular involvement and tumor resectability on CT in patients with pancreatic cancer.
Bereska JI; Janssen BV; Nio CY; Kop MPM; Kazemier G; Busch OR; Struik F; Marquering HA; Stoker J; Besselink MG; Verpalen IM;
Eur Radiol Exp; 2024 Feb; 8(1):18. PubMed ID: 38342782
[TBL] [Abstract] [Full Text] [Related]
3. Association between hospital volume and outcomes in invasive ovarian cancer in Belgium: A population-based study.
Savoye I; Silversmit G; Bourgeois J; De Gendt C; Leroy R; Peacock HM; Stordeur S; de Sutter P; Goffin F; Luyckx M; Orye G; Van Dam P; Van Gorp T; Verleye L
Eur J Cancer; 2023 Dec; 195():113402. PubMed ID: 37922631
[TBL] [Abstract] [Full Text] [Related]
4. treatment of Recurrent Low-grade Serous Ovarian cancer With MEK Inhibitors: A Systematic Review.
Kulkarni A; Cooke C; Fazelzad R; Fung-Kee-Fung M; May T; Zigras T
Am J Clin Oncol; 2024 Jan; 47(1):11-16. PubMed ID: 37823720
[TBL] [Abstract] [Full Text] [Related]
5. Bevacizumab treatment for Low-Grade Serous Ovarian cancer: A Systematic Review.
Lazurko C; Linder R; Pulman K; Lennox G; Feigenberg T; Fazelzad R; May T; Zigras T
Curr Oncol; 2023 Sep; 30(9):8159-8171. PubMed ID: 37754507
[TBL] [Abstract] [Full Text] [Related]
6. Lateral neck dissection for the treatment of synchronous and metachronous lateral neck metastasis of N1b papillary thyroid cancer.
Yun HJ; Lee JS; Lee JS; Kim SM; Chang H; Lee YS; Chang HS; Park CS
Front Endocrinol (Lausanne); 2023; 14():1166640. PubMed ID: 37424860
[TBL] [Abstract] [Full Text] [Related]
7. Comparison of survival for metastatic pancreatic cancer patients treated with CPI-613 versus resected borderline-resectable pancreatic cancer patients.
Mangieri CW; Valenzuela CD; Solsky IB; Erali RA; Pardee T; Lima CMSR; Howerton R; Clark CJ; Shen P
J Surg Oncol; 2023 Oct; 128(5):844-850. PubMed ID: 37341164
[TBL] [Abstract] [Full Text] [Related]
8. A retrospective analysis of secondary cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in patients with recurrent ovarian cancer.
Yang D; Zhang Y; Gong P; Liu F; Gan Y; Bai W
J Obstet Gynaecol Res; 2023 Jul; 49(7):1795-1804. PubMed ID: 37231941
[TBL] [Abstract] [Full Text] [Related]
9. Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study.
Remde H; Kranz S; Morell SM; Altieri B; Kroiss M; Detomas M; Fassnacht M; Deutschbein T
Front Endocrinol (Lausanne); 2023; 14():1123132. PubMed ID: 37223045
[TBL] [Abstract] [Full Text] [Related]
10. Lymphocyte-activation gene 3 protein expression in tumor-infiltrating lymphocytes is associated with a poor prognosis of ovarian clear cell carcinoma.
Zaitsu S; Yano M; Adachi S; Miwa M; Katoh T; Kawano Y; Yasuda M
J Ovarian Res; 2023 May; 16(1):93. PubMed ID: 37179337
[TBL] [Abstract] [Full Text] [Related]
11. A secondary CD34+ acute lymphoblastic leukemia unmasked and mobilized by G-CSF in an autologous stem cell donor with testicular cancer.
Cooling L; Kelley J; Sexton E; Anand S; Hoffmann S
Transfusion; 2023 Apr; 63(4):684-689. PubMed ID: 36762622
[TBL] [Abstract] [Full Text] [Related]
12. Clinical characteristics and survival analysis of Chinese ovarian cancer patients with RAD51D germline mutations.
Yao H; Li N; Yuan H
BMC Cancer; 2022 Dec; 22(1):1337. PubMed ID: 36544182
[TBL] [Abstract] [Full Text] [Related]
13. Incidence and appropriate management of drug-induced interstitial lung disease in Japanese patients with unresectable pancreatic cancer: A multicenter retrospective study.
Miyagahara T; Fujimori N; Ueda K; Takamatsu Y; Matsumoto K; Teramatsu K; Takaoka T; Suehiro Y; Shimokawa Y; Omori K; Niina Y; Tachibana Y; Akashi T; Oono T; Ogawa Y
Asia Pac J Clin Oncol; 2023 Aug; 19(4):533-541. PubMed ID: 36478079
[TBL] [Abstract] [Full Text] [Related]
14. Comparison of MRI and CT-based radiomics for preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma.
Zeng P; Qu C; Liu J; Cui J; Liu X; Xiu D; Yuan H
Acta Radiol; 2023 Jul; 64(7):2221-2228. PubMed ID: 36474439
[TBL] [Abstract] [Full Text] [Related]
15. Single-cell sequencing reveals effects of chemotherapy on the immune landscape and TCR/bcr clonal expansion in a relapsed ovarian cancer patient.
Ren Y; Li R; Feng H; Xie J; Gao L; Chu S; Li Y; Meng F; Ning Y
Front Immunol; 2022; 13():985187. PubMed ID: 36248860
[TBL] [Abstract] [Full Text] [Related]
16. The factors associated with the persistence of hypogonadism in male patients with prolactinoma.
Piskinpasa H; Turgut S
Neuro Endocrinol Lett; 2022 Sep; 43(3):154-160. PubMed ID: 36179726
[TBL] [Abstract] [Full Text] [Related]
17. Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9
Santamaria S; Delgado M; Botas M; Castellano E; Corraliza-Gorjon I; Lafuente P; Muñoz-Calleja C; Toribio ML; Kremer L; Garcia-Sanz JA
Front Immunol; 2022; 13():825635. PubMed ID: 35967322
[TBL] [Abstract] [Full Text] [Related]
18. Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism.
Kumstel S; Schreiber T; Goldstein L; Stenzel J; Lindner T; Joksch M; Zhang X; Wendt EHU; Schönrogge M; Krause B; Vollmar B; Zechner D
PLoS One; 2022; 17(4):e0266601. PubMed ID: 35452495
[TBL] [Abstract] [Full Text] [Related]
19. Development of hypothyroidism over 13 years of follow-up of patients with hyperthyroidism after radioiodine therapy.
Li JF; Xie LJ; Qin LP; Wan QC; Li JP; Wu QY; Cheng MH
Hell J Nucl Med; 2022; 25(1):26-31. PubMed ID: 35388801
[TBL] [Abstract] [Full Text] [Related]
20. Survival benefits of retroperitoneal lymphadenectomy for optimally-resected advanced ovarian high-grade serous carcinoma: a multi-institutional retrospective study.
Ikeda Y; Yoshihara M; Tamauchi S; Yokoi A; Yoshikawa N; Kajiyama H
J Gynecol Oncol; 2022 Jul; 33(4):e40. PubMed ID: 35320889
[TBL] [Abstract] [Full Text] [Related]
[Next]
